Sandu Pharmaceuticals Reports Flat Performance in Q1 2024, PAT and EPS Show Positive Growth

Jun 07 2024 09:46 AM IST
share
Share Via
Sandu Pharmaceuticals, a microcap trading company, reported its financial results for the quarter ending March 2024. The company's stock has been given a 'Strong Sell' rating by MarketsMojo. While the Profit After Tax and Earnings per Share have shown improvement, the Net Sales have decreased, indicating a mixed performance for the quarter. Investors are advised to carefully evaluate before investing.

Sandu Pharmaceuticals, a microcap trading company, recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Strong Sell' rating by MarketsMOJO.

According to the financial report, Sandu Pharma's performance for the quarter has remained flat, with a score of 1 out of 10. However, this is an improvement from the previous quarter's score of 0.

One of the positive aspects of the company's financials is its Profit After Tax (PAT), which has been the highest in the last five quarters at Rs 0.59 crore. The near-term trend for PAT is also positive, indicating potential growth for the company. Similarly, the Earnings per Share (EPS) for the quarter has also been the highest in the last five quarters at Rs 0.61, showing an increase in profitability and creating higher earnings for shareholders.

On the other hand, the company's Net Sales for the quarter have fallen by -6.8% compared to the average Net Sales of the previous four quarters. This indicates a negative trend in sales for the near term.

Overall, Sandu Pharmaceuticals has shown mixed results in its financial performance for the quarter ending March 2024. Investors are advised to carefully consider all factors before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read